Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
Experimental and Therapeutic Medicine
Join Editorial Board Propose a Special Issue
Print ISSN: 1792-0981 Online ISSN: 1792-1015
Journal Cover
September-2020 Volume 20 Issue 3

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
September-2020 Volume 20 Issue 3

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML
Article Open Access

Thromboelastography maximum amplitude predicts short‑term mortality in patients with hepatitis B virus‑related acute‑on‑chronic liver failure

  • Authors:
    • Zhe Zhu
    • Yong Yu
    • Yefang Ke
    • Danfei Deng
    • Guodong  Zheng
    • Xin Hua
    • Guosheng Gao
  • View Affiliations / Copyright

    Affiliations: Department of Blood Transfusion, Hwa Mei Hospital, University of Chinese Academy of Sciences, Ningbo, Zhejiang 315010, P.R. China, Department of Clinical Laboratory, Ningbo Women and Children's Hospital, Ningbo, Zhejiang 315012, P.R. China , Ningbo Institute of Life and Health Industry, University of Chinese Academy of Sciences, Ningbo, Zhejiang 315010, P.R. China
    Copyright: © Zhu et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
  • Pages: 2657-2664
    |
    Published online on: July 13, 2020
       https://doi.org/10.3892/etm.2020.8990
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

Patients with hepatitis B virus (HBV)‑related acute‑on‑chronic liver failure (ACLF) exhibit complex hemostatic defects. Thromboelastography (TEG) can be used to reveal global hemostasis in patients with liver disease; however, little is known about the association between TEG and the outcome of patients with HBV‑related ACLF. The present study aimed to investigate the value of TEG for predicting 90 day mortality in patients with HBV‑related ACLF. A total of 51 patients with HBV‑related ACLF, 26 patients with chronic hepatitis B (CHB) and 26 healthy controls (HC) were enrolled in the present study. TEG, standard coagulation tests, routine blood tests, biochemical markers and demographic variables were recorded and assessed for prognostic value. The results indicated that a prolonged reaction and kinetics (K) time, a shortened α angle and a decreased maximum amplitude (MA) and coagulation index (CI) were observed in patients with HBV‑related ACLF, compared with CHB and HC subjects. Patients with HBV‑related ACLF in the mortality group exhibited a decrease in α angle, MA, lysis at 30 min, CI, fibrinogen and platelet count, and an increase in K time, international normalized ratio (INR) and the model for end‑stage liver disease (MELD) score in comparison with the survival group. MA and INR were two independent predictors of 90 day mortality in patients with HBV‑related ACLF, with hazard ratios of 0.918 (95% CI, 0.867‑0.971; P=0.003) and 3.141 (95% CI, 1.843‑5.354; P<0.001) respectively. When predicting 90 day mortality, MA + INR exhibited the highest area under the receiver operating characteristic curve, followed by INR, MELD score and MA. Patients with ACLF and MA ≤51.5 mm exhibited a poorer outcome than those with MA >51.5 mm, as revealed via the Kaplan‑Meier analysis. In summary, the findings of the present study suggested that TEG MA was associated with 90 day mortality in patients with HBV‑related ACLF, and a combination of MA and INR was superior to MA, INR and MELD score in terms of prognostic value.
View Figures

Figure 1

Figure 2

Figure 3

View References

1 

Zhao RH, Shi Y, Zhao H, Wu W and Sheng JF: Acute-on-chronic liver failure in chronic hepatitis B: An update. Expert Rev Gastroenterol Hepatol. 12:341–350. 2018.PubMed/NCBI View Article : Google Scholar

2 

Jalan R, Saliba F, Pavesi M, Amoros A, Moreau R, Ginès P, Levesque E, Durand F, Angeli P, Caraceni P, et al: CANONIC study investigators of the EASL-CLIF Consortium: Development and validation of a prognostic score to predict mortality in patients with acute-on-chronic liver failure. J Hepatol. 61:1038–1047. 2014.PubMed/NCBI View Article : Google Scholar

3 

Wu T, Li J, Shao L, Xin J, Jiang L, Zhou Q, Shi D, Jiang J, Sun S, Jin L, et al: Chinese Group on the Study of Severe Hepatitis B (COSSH): Development of diagnostic criteria and a prognostic score for hepatitis B virus-related acute-on-chronic liver failure. Gut. 67:2181–2191. 2018.PubMed/NCBI View Article : Google Scholar

4 

Sarin SK, Kedarisetty CK, Abbas Z, Amarapurkar D, Bihari C, Chan AC, Chawla YK, Dokmeci AK, Garg H, Ghazinyan H, et al: APASL ACLF Working Party: Acute-on-chronic liver failure: Consensus recommendations of the Asian Pacific Association for the Study of the Liver (APASL) 2014. Hepatol Int. 8:453–471. 2014.PubMed/NCBI View Article : Google Scholar

5 

Chau TN, Chan YW, Patch D, Tokunaga S, Greenslade L and Burroughs AK: Thrombelastographic changes and early rebleeding in cirrhotic patients with variceal bleeding. Gut. 43:267–271. 1998.PubMed/NCBI View Article : Google Scholar

6 

Shin KH, Kim IS, Lee HJ, Kim HH, Chang CL, Hong YM, Yoon KT and Cho M: Thromboelastographic Evaluation of Coagulation in Patients With Liver Disease. Ann Lab Med. 37:204–212. 2017.PubMed/NCBI View Article : Google Scholar

7 

Tripodi A and Mannucci PM: The coagulopathy of chronic liver disease. N Engl J Med. 365:147–156. 2011.PubMed/NCBI View Article : Google Scholar

8 

Hawkins RB, Raymond SL, Hartjes T, Efron PA, Larson SD, Andreoni KA and Thomas EM: Review: The perioperative use of thromboelastography for liver transplant patients. Transplant Proc. 50:3552–3558. 2018.PubMed/NCBI View Article : Google Scholar

9 

Wang SC, Shieh JF, Chang KY, Chu YC, Liu CS, Loong CC, Chan KH, Mandell S and Tsou MY: Thromboelastography-guided transfusion decreases intraoperative blood transfusion during orthotopic liver transplantation: Randomized clinical trial. Transplant Proc. 42:2590–2593. 2010.PubMed/NCBI View Article : Google Scholar

10 

De Pietri L, Bianchini M, Montalti R, De Maria N, Di Maira T, Begliomini B, Gerunda GE, di Benedetto F, Garcia-Tsao G and Villa E: Thrombelastography-guided blood product use before invasive procedures in cirrhosis with severe coagulopathy: A randomized, controlled trial. Hepatology. 63:566–573. 2016.PubMed/NCBI View Article : Google Scholar

11 

Trautman CL, Palmer WC, Taner CB, Canabal JM, Getz T, Goldman A, Heckman MG, Diehl NN, Lee DD and Stancampiano FF: Thromboelastography as a Predictor of Outcomes Following Liver Transplantation. Transplant Proc. 49:2110–2116. 2017.PubMed/NCBI View Article : Google Scholar

12 

Premkumar M, Saxena P, Rangegowda D, Baweja S, Mirza R, Jain P, Bhatia P, Kumar G, Bihari C, Kalal C, et al: Coagulation failure is associated with bleeding events and clinical outcome during systemic inflammatory response and sepsis in acute-on-chronic liver failure: An observational cohort study. Liver Int. 39:694–704. 2019.PubMed/NCBI View Article : Google Scholar

13 

Blasi A, Calvo A, Prado V, Reverter E, Reverter JC, Hernández-Tejero M, Aziz F, Amoros A, Cardenas A and Fernández J: Coagulation failure in patients with acute-on-chronic liver failure and decompensated cirrhosis: Beyond the international normalized ratio. Hepatology. 68:2325–2337. 2018.PubMed/NCBI View Article : Google Scholar

14 

Shi Y, Yang Y, Hu Y, Wu W, Yang Q, Zheng M, Zhang S, Xu Z, Wu Y, Yan H, et al: Acute-on-chronic liver failure precipitated by hepatic injury is distinct from that precipitated by extrahepatic insults. Hepatology. 62:232–242. 2015.PubMed/NCBI View Article : Google Scholar

15 

Lin W, Zhang J, Liu X, Liu H, He J, Li M, Zhang S, Zhang Y, Chen H, Zhang C, et al: A Dynamic model for predicting outcome in patients with HBV related acute-on-chronic liver failure. Ann Hepatol. 17:392–402. 2018.PubMed/NCBI View Article : Google Scholar

16 

Peng Y, Qi X, Tang S, Deng H, Li J, Ning Z, Dai J, Hou F, Zhao J, Wang R, et al: Child-Pugh, MELD, and ALBI scores for predicting the in-hospital mortality in cirrhotic patients with acute-on-chronic liver failure. Expert Rev Gastroenterol Hepatol. 10:971–980. 2016.PubMed/NCBI View Article : Google Scholar

17 

Stravitz RT: Potential applications of thromboelastography in patients with acute and chronic liver disease. Gastroenterol Hepatol (NY). 8:513–520. 2012.PubMed/NCBI

18 

Reikvam H, Steien E, Hauge B, Liseth K, Hagen KG, Størkson R and Hervig T: Thrombelastography. Transfus Apheresis Sci. 40:119–123. 2009.PubMed/NCBI View Article : Google Scholar

19 

Fisher C, Patel VC, Stoy SH, Singanayagam A, Adelmeijer J, Wendon J, Shawcross DL, Lisman T and Bernal W: Balanced haemostasis with both hypo- and hyper-coagulable features in critically ill patients with acute-on-chronic-liver failure. J Crit Care. 43:54–60. 2018.PubMed/NCBI View Article : Google Scholar

20 

Lloyd-Donald P, Vasudevan A, Angus P, Gow P, Mårtensson J, Glassford N, Eastwood GM, Hart GK and Bellomo R: Coagulation in acutely ill patients with severe chronic liver disease: Insights from thromboelastography. J Crit Care. 38:215–224. 2017.PubMed/NCBI View Article : Google Scholar

21 

Goyal S, Jadaun S, Kedia S, Kumar-Acharya S, Varma S, Nayak B, Thakur B and M D S: Thromboelastography Parameters in Patients with Acute on Chronic Liver Failure. Ann Hepatol. 17:1042–1051. 2018.PubMed/NCBI View Article : Google Scholar

22 

Dai J, Qi X, Li H and Guo X: Role of D-dimer in the development of portal vein thrombosis in liver cirrhosis: A meta-analysis. Saudi J Gastroenterol. 21:165–174. 2015.PubMed/NCBI View Article : Google Scholar

23 

Li Y, Qi X, Li H, Dai J, Deng H, Li J, Peng Y, Liu X, Sun X and Guo X: D-dimer level for predicting the in-hospital mortality in liver cirrhosis: A retrospective study. Exp Ther Med. 13:285–289. 2017.PubMed/NCBI View Article : Google Scholar

24 

Lisman T, Bakhtiari K, Adelmeijer J, Meijers JC, Porte RJ and Stravitz RT: Intact thrombin generation and decreased fibrinolytic capacity in patients with acute liver injury or acute liver failure. J Thromb Haemost. 10:1312–1319. 2012.PubMed/NCBI View Article : Google Scholar

25 

Leebeek FW and Rijken DC: The fibrinolytic status in liver diseases. Semin Thromb Hemost. 41:474–480. 2015.PubMed/NCBI View Article : Google Scholar

26 

Stravitz RT, Ellerbe C, Durkalski V, Reuben A, Lisman T and Lee WM: Acute Liver Failure Study G. Thrombocytopenia is associated with multi organ system failure in patients with acute liver failure. Clin Gastroenterol Hepatol. 14:613–620 e614. 2016.PubMed/NCBI View Article : Google Scholar

27 

Beilin Y, Arnold I and Hossain S: Evaluation of the platelet function analyzer (PFA-100) vs. the thromboelastogram (TEG) in the parturient. Int J Obstet Anesth. 15:7–12. 2006.PubMed/NCBI View Article : Google Scholar

28 

Vinholt PJ, Hvas AM, Nielsen C, Söderström AC, Sprogøe U, Fialla AD and Nybo M: Reduced platelet activation and platelet aggregation in patients with alcoholic liver cirrhosis. Platelets. 29:520–527. 2018.PubMed/NCBI View Article : Google Scholar

29 

Shi X, Zhu P, Yan G, Liu C, Zhang C, Huang G, Zhang Y, Yan Z and Wang Y: Clinical characteristics and long-term outcome of acute kidney injury in patients with HBV-related acute-on-chronic liver failure. J Viral Hepat. 23:920–929. 2016.PubMed/NCBI View Article : Google Scholar

30 

Lisman T and Luyendyk JP: Platelets as modulators of liver diseases. Semin Thromb Hemost. 44:114–125. 2018.PubMed/NCBI View Article : Google Scholar

31 

Li N, Huang C, Yu KK, Lu Q, Shi GF and Zheng JM: Validation of prognostic scores to predict short-term mortality in patients with HBV-related acute-on-chronic liver failure: The CLIF-C OF is superior to MELD, CLIF SOFA, and CLIF-C ACLF. Medicine (Baltimore). 96(e6802)2017.PubMed/NCBI View Article : Google Scholar

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Zhu Z, Yu Y, Ke Y, Deng D, Zheng G, Hua X and Gao G: Thromboelastography maximum amplitude predicts short‑term mortality in patients with hepatitis B virus‑related acute‑on‑chronic liver failure. Exp Ther Med 20: 2657-2664, 2020.
APA
Zhu, Z., Yu, Y., Ke, Y., Deng, D., Zheng, G., Hua, X., & Gao, G. (2020). Thromboelastography maximum amplitude predicts short‑term mortality in patients with hepatitis B virus‑related acute‑on‑chronic liver failure. Experimental and Therapeutic Medicine, 20, 2657-2664. https://doi.org/10.3892/etm.2020.8990
MLA
Zhu, Z., Yu, Y., Ke, Y., Deng, D., Zheng, G., Hua, X., Gao, G."Thromboelastography maximum amplitude predicts short‑term mortality in patients with hepatitis B virus‑related acute‑on‑chronic liver failure". Experimental and Therapeutic Medicine 20.3 (2020): 2657-2664.
Chicago
Zhu, Z., Yu, Y., Ke, Y., Deng, D., Zheng, G., Hua, X., Gao, G."Thromboelastography maximum amplitude predicts short‑term mortality in patients with hepatitis B virus‑related acute‑on‑chronic liver failure". Experimental and Therapeutic Medicine 20, no. 3 (2020): 2657-2664. https://doi.org/10.3892/etm.2020.8990
Copy and paste a formatted citation
x
Spandidos Publications style
Zhu Z, Yu Y, Ke Y, Deng D, Zheng G, Hua X and Gao G: Thromboelastography maximum amplitude predicts short‑term mortality in patients with hepatitis B virus‑related acute‑on‑chronic liver failure. Exp Ther Med 20: 2657-2664, 2020.
APA
Zhu, Z., Yu, Y., Ke, Y., Deng, D., Zheng, G., Hua, X., & Gao, G. (2020). Thromboelastography maximum amplitude predicts short‑term mortality in patients with hepatitis B virus‑related acute‑on‑chronic liver failure. Experimental and Therapeutic Medicine, 20, 2657-2664. https://doi.org/10.3892/etm.2020.8990
MLA
Zhu, Z., Yu, Y., Ke, Y., Deng, D., Zheng, G., Hua, X., Gao, G."Thromboelastography maximum amplitude predicts short‑term mortality in patients with hepatitis B virus‑related acute‑on‑chronic liver failure". Experimental and Therapeutic Medicine 20.3 (2020): 2657-2664.
Chicago
Zhu, Z., Yu, Y., Ke, Y., Deng, D., Zheng, G., Hua, X., Gao, G."Thromboelastography maximum amplitude predicts short‑term mortality in patients with hepatitis B virus‑related acute‑on‑chronic liver failure". Experimental and Therapeutic Medicine 20, no. 3 (2020): 2657-2664. https://doi.org/10.3892/etm.2020.8990
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team